Gut Microbiota Influence on Drug Metabolism

Gut microbiota shape drug metabolism through direct and indirect mechanisms that affect therapeutic outcomes. Microbial enzymes can catalyse the biotransformation of xenobiotics, altering bioavailability, efficacy and toxicity. Conversely, pharmaceuticals influence microbial composition and function, leading to feedback effects on drug handling. These bidirectional interactions occur at the level of absorption, distribution, metabolism and excretion (ADME) and contribute substantially to inter-individual variability in drug response. Key pathways include microbial reduction, hydrolysis and deconjugation, alongside modulation of host hepatic and intestinal enzyme systems. Variations in microbial gene content and metabolic capacity have been linked to the inactivation of cardiac glycosides, modulation of chemotherapeutic efficacy and altered lipid-lowering responses. Such insights have underpinned the emergence of pharmacomicrobiomics, which integrates host genomics, microbial multi-omics and environmental factors to tailor therapy. Harnessing the gut microbiota holds promise for precision medicine through predictive biomarkers, microbiome-targeted co-therapies and dietary interventions that optimise drug safety and efficacy on a global scale.

Research from Nature Portfolio

Human cohort analyses have mapped associations between gut microbial profiles and both common diseases and prescription medications, revealing specific taxa that correlate with therapeutic classes and health outcomes. This foundational work provides a reference framework for dissecting microbe-drug interactions and prioritising candidate microbes for mechanistic studies. In parallel, experimental investigations using rodent models of diet-induced hypercholesterolaemia have shown that atorvastatin not only lowers serum lipids but also reshapes the gut microbiota, restoring key taxa and increasing microbial diversity. These findings suggest that part of the drug’s efficacy and side-effect profile may be mediated by its impact on microbial ecosystems, offering new avenues for adjunctive microbiome modulation.

Gut Microbiota Influence on Drug Metabolism publication trend

The graph below shows the total number of articles in gut microbiota influence on drug metabolism across all publications each year (not limited to Nature Index journals).

Technical terms

Gut microbiota: The community of microorganisms residing in the gastrointestinal tract.

Pharmacokinetics: The study of how an organism affects a drug, including ADME processes.

Pharmacodynamics: The study of the biochemical and physiological effects of drugs and their mechanisms of action.

ADME: The collective processes of absorption, distribution, metabolism and excretion of compounds.

Xenobiotic: A chemical substance foreign to a biological system, such as a drug or environmental toxin.

Pharmacomicrobiomics: The study of interactions between host microbiome composition and drug response variability.

References

1. Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduction and Targeted Therapy (2023).
2. Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacological Reviews (2019).
3. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes (2014).
4. Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans. Cell (2017).
5. Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment. PLOS ONE (2011).
6. Pharmacomicrobiomics: a novel route towards personalized medicine?. Protein & Cell (2018).
7. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nature Communications (2018).
8. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Scientific Reports (2018).
9. Interaction between drugs and the gut microbiome. Gut (2020).
10. A new evaluation system for drug–microbiota interactions. iMeta (2024).